TOMSK, RUSSIA / RankWire.AI / – Russian scientists have evaluated a new bioactive coating aimed at enhancing the interaction between titanium orthopedic implants and bone tissue. The material incorporates calcium phosphate sourced from hydroxyapatite and includes nitrogen compounds linked to nitric oxide synthesis. In laboratory experiments, the coated surfaces demonstrated a significantly higher survival rate for human mesenchymal stem cells compared to uncoated titanium. The team studied the coating’s structure, chemical makeup, mechanical qualities, and biological response. Their peer-reviewed results appeared in Applied Surface Science in 2026.
At Tomsk Polytechnic University, researchers created the experimental coatings by reactive magnetron sputtering of a hydroxyapatite target within a vacuum chamber. They manipulated the ratio of nitrogen to argon during deposition to observe how each mixture influenced the final surface characteristics. The study tested five different conditions, ranging from pure nitrogen to pure argon. The scientists measured coating thickness, surface morphology, hardness, wettability, and chemical composition. Additionally, they conducted laboratory assessments to understand how living human cells reacted to the modified titanium surfaces.
The results indicated that the argon level impacted several physical properties of the coatings. Surfaces created with pure argon were denser and harder compared to those deposited with pure nitrogen. Increasing the argon proportion also led to thicker coatings. Chemical analyses detected nitrogen-carbon and nitrogen-oxygen bonds on the treated surfaces. Subsequently, the team compared the behavior of human mesenchymal stem cells grown on coated titanium with cells on uncoated titanium. The biological tests focused on cell viability and markers associated with bone cell differentiation.
Enhanced Cell Survival Observed in Coated Samples
The experiments revealed that coated surfaces supported significantly better cell survival than uncoated titanium, according to the study. After a week, coatings with increased nitrogen content also led to decreased activity in certain genes linked to early bone-cell differentiation. Nevertheless, the cells retained their ability to form bone despite these early gene activity changes. The researchers conducted these tests in controlled laboratory conditions using human mesenchymal stem cells. It is important to note that the study did not involve testing the coating in patients nor did it assess clinical performance of implanted devices.
The biomedical evaluation was carried out by specialists from Immanuel Kant Baltic Federal University and Siberian State Medical University. The wider research team also included scientists from Saint Petersburg State University. This project was supported through Russia’s national science program. The researchers aimed to identify gas mixtures that could produce beneficial combinations of physical, chemical, and biological coating properties. Hydroxyapatite is already used in implant coatings because its calcium phosphate makeup closely resembles the mineral component of human bone.
Research Still at the Laboratory Stage
The team has outlined plans for further testing beyond the initial seven-day cell analysis. They intend to examine stem cells over periods of 10 to 28 days and to evaluate the rate at which the coatings dissolve. Additionally, they plan to measure nitric oxide release into surrounding tissues in living organisms. These investigations, however, were not part of the current published results. Presently, the focus remains on coated titanium substrates, their physical and chemical properties, and cellular responses in vitro, rather than clinical outcomes for orthopaedic patients.
The data presented offer detailed insights into how varying ratios of nitrogen and argon influence calcium phosphate coatings applied to titanium surfaces. The research documented differences in coating thickness, density, hardness, chemical bonds, and cellular reactions across the tested gas mixtures. It also confirmed that coated samples supported higher survival rates of stem cells than uncoated titanium under laboratory conditions. Nevertheless, the study remains at the preclinical stage, with no safety or efficacy claims made for use in human patients. Additional biological testing will be necessary to explore properties not covered in this initial research.